MedPath

The Effects of Single-dose Rectal Midazolam Application on Post-operative Recovery

Phase 4
Completed
Conditions
Failed Moderate Sedation During Procedure
Interventions
Drug: 1 mL/kg bupivacaine 0.25%.
Registration Number
NCT02127489
Lead Sponsor
Karadeniz Technical University
Brief Summary

This study aimed to compare the efficiency of rectal midazolam addition after applying bupivacaine and caudal anesthesia on postoperative analgesia time, the need for additional analgesics, postoperative recovery, sedation, and to find out its adverse effects in children having lower abdominal surgery.

Detailed Description

Summary Background: This study aimed to compare the efficiency of rectal midazolam addition after applying bupivacaine and caudal anesthesia on postoperative analgesia time, the need for additional analgesics, postoperative recovery, sedation, and to find out its adverse effects in children having lower abdominal surgery.

Methods: 40 children between 2 and 10 years of American Society of Anesthesiologist (ASA) I-II stages were randomized and applied caudal anesthesia under general anesthesia. Patients were applied caudal block in addition with saline and 1milliliter/kilograms (mL/kg) bupivacaine 0.25%. In the postoperative period, Group C (n=20) was given 5 milliliter (mL) saline and Group M (n=20) was given 0.30 mg/kg rectal midazolam diluted with 5mL saline. Sedation scale and postoperative pain scale (CHIPPS) of the patients were evaluated. The patients were observed for their analgesic need, first analgesic time, and adverse effects for 24 hours.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • children having lower abdominal surgery
Exclusion Criteria
  • Children with significant respiratory system, circulatory system, liver, and kidney function disorder, history of allergy to the drugs to be studied, those who received analgesic medication before the operation, and those for whom caudal anesthesia is contraindicated

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Midazolam1 mL/kg bupivacaine 0.25%.1 mL/kg bupivacaine 0.25%.
saline1 mL/kg bupivacaine 0.25%.5mL rectal saline
Primary Outcome Measures
NameTimeMethod
Sedation scale and postoperative pain scale (CHIPPS)24 hours

Sedation scale and postoperative pain scale (CHIPPS) of the patients were evaluated. The patients were observed for their analgesic need, first analgesic time, and adverse effects for 24 hours.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Karadeniz Technical University Faculty of Medicine

🇹🇷

Trabzon, Turkey

© Copyright 2025. All Rights Reserved by MedPath